New Study Reveals Fertility Treatments May Increase DNA Errors in Mice
A recent study has uncovered a surprising connection between fertility treatments and DNA mutations in mice. The research, published in the journal Genome Research, suggests that pups conceived through in vitro fertilization (IVF) in the lab exhibit slightly higher rates of DNA errors, or mutations, compared to naturally conceived pups. While the findings do not directly apply to humans, they highlight the importance of understanding the impact of fertility treatments on offspring DNA.
The study, led by geneticist Beth Dumont at The Jackson Laboratory, compared the genome sequences of lab mice conceived naturally and those conceived through assisted reproductive technologies, including hormone treatments, IVF, and embryo transfer. The results revealed that pups born through these fertility treatments had approximately 30% more new single-nucleotide variants, or tiny changes in DNA sequences, compared to naturally conceived mice.
Despite the increased mutation rates, Dumont emphasizes that the observed mutations are unlikely to be harmful. Scientists estimate that fewer than 2% of new mutations are deleterious, and the mutations in this study were spread across the genome, indicating a neutral effect on the organism's phenotype. The timing of these mutations in early embryos also appeared similar between fertility-treated and natural groups, suggesting that fertility treatment increases the overall chance of new DNA changes but does not impact their occurrence during development.
The study's findings raise important questions about the risks and possible causes of these genetic changes. While the absolute number of harmful new mutations per mouse remains low, with about one additional harmful DNA change per 50 mice conceived with IVF, the biological mechanisms underlying these changes are not yet clear. Further research is needed to determine whether the new mutations arise from specific steps in the IVF process or from the combined effects of multiple steps.
One possible factor is the use of hormone treatments that stimulate the ovaries, as these hormones can push eggs to restart meiosis, a stage of cell division known to be prone to mistakes. Other aspects of the fertility treatment protocol, such as physical handling of embryos or the chemical conditions of the lab culture environment, may also play a role.
It's crucial to note that the study does not directly translate to human IVF. Fertility procedures and reproductive biology differ between mice and humans. For instance, mice do not menstruate, and people seeking IVF may already be exposed to environmental factors that could have affected their genetics. Dumont emphasizes the need for further research to ensure patients are fully informed about the potential risks associated with fertility treatments.
The study's authors include Laura Blanco-Berdugo and Alexis Garretson of The Jackson Laboratory. The research highlights the ongoing need for scientific exploration and understanding in the field of reproductive health.
